The global drug of abuse testing market was valued at US$2.99 bn in 2015 and is anticipated to reach US$3.44 bn by 2018 at a CAGR of 4.8% between 2013 and 2018. The leading as well as the fastest growing regional market by revenue in the global drug of abuse testing market was North America in 2015 and is anticipated to remain so by the end of 2018. In 2015, the valuation of the North America market is US$2.27 bn and is expected to rise to US$2.66 bn by 2018. The substantial growth of this region can be attributed to growing cases of drug abuse.
Request a Free PDF Brochure with Report Analysis:
Some of the key driving factors for the drugs of abuse testing market are globally rising consumption of illicit drugs, adoption of drug of abuse (DOA) testing at organizational level, increased production of illicit drugs and their trade and increasing death rates/road accidents due to drug abuse. However, the market faces some restraints such as social concerns associated with illicit drugs testing, legalization of various drugs, and economic volatility and cost concerns.
North America, including the US has the largest drugs of abuse testing market and also the fastest growing drugs of abuse testing market. Some of the fastest growing markets for drugs of abuse testing are US, UK, Japan, Germany and other European countries. According to UNODC report 2013, number of illicit drug users is estimated to increase from 167 million in 2009 to 315 million people in 2011. This corresponds to 3.6% to 6.9% of global adult population; cannabis, opioids and opiates were most commonly used illicit drugs. In various countries, such as in America and Europe, organizations are conducting drug screening test at various levels, such as pre-employment screening, random drug/alcohol screening, post incident drug/alcohol screening and abstinence monitoring.
In many countries, government rules & regulations are also supporting drugs of abuse testing market to grow, as they have outlined essential drug testing at workplace, such as in the US, Japan, Australia and the UK. This has emerged as a key driver for the market
Urine is the largest sample which is diagnosed in the drugs of abuse testing market and it is expected to grow at a CAGR of about 5.0% during 2013 – 2018. Some of the other major samples for drugs of abuse testing are Saliva and Hair. Laboratory drug screening test requires a trained and skilled person to provide an accurate result and involves in-depth analysis. In laboratory screening test, usually the test is reconfirmed using gas chromatography/mass spectrometry or any other superior techniques to provide accurate results. On-site drug screening test gives immediate results on the spot. It is generally preferred by those who take the drug test at home, workplace and educational institutions. The most common specimens used in on-site drug testing are urine, saliva and hair. Nowadays, commercially-available on-site screening test kits are usually designed for urine and saliva specimens only.
Roche Diagnostics is the leading player in the global drugs of abuse testing market. Other major players of drugs of abuse testing market include Quest Diagnostics, LabCorp, Alere and Abbott Laboratories and others.